**Core Concept**
The question is testing the understanding of the pathogenesis of atherosclerosis, specifically the development of atherosclerotic plaques. The organism in question is likely referring to the bacteria *Chlamydia pneumoniae*, which has been implicated in the development of atherosclerosis.

**Why the Correct Answer is Right**
In later phases of plaque development, the lipid core of the plaque becomes more prominent, and the inflammatory response is driven by the presence of various pathogens, including *Chlamydia pneumoniae*. This organism is thought to infect macrophages and smooth muscle cells within the plaque, leading to an inflammatory response and further progression of the plaque. The presence of *Chlamydia pneumoniae* in atherosclerotic plaques is associated with increased plaque instability and a higher risk of cardiovascular events.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not specify the organism that predominates in later phases of plaque development. While other pathogens may be present in atherosclerotic plaques, *Chlamydia pneumoniae* is specifically implicated in the later stages of plaque development.
* **Option B:** This option is incorrect because it does not address the organism that predominates in later phases of plaque development. The development of atherosclerosis is a complex process involving multiple factors, but *Chlamydia pneumoniae* is specifically associated with the later stages of plaque development.
* **Option D:** This option is incorrect because it is too vague and does not specify the organism that predominates in later phases of plaque development. While bacteria may be present in atherosclerotic plaques, *Chlamydia pneumoniae* is specifically implicated in the later stages of plaque development.

**Clinical Pearl / High-Yield Fact**
*Chlamydia pneumoniae* infection is associated with an increased risk of atherosclerotic cardiovascular disease, and antibiotic treatment has been shown to reduce the risk of cardiovascular events in patients with atherosclerosis. This highlights the potential role of infection in the development of atherosclerosis and the importance of considering antibiotic treatment in patients with atherosclerotic cardiovascular disease.

**Correct Answer:** D.